| |
| |
|
| Insider
Information: |
Leonard Braden Michael |
| Relationship: |
|
| City: |
Zionsville |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
3,590,812 |
|
|
Indirect Shares
|
45,629,696 |
|
|
| Direct
Value |
$16,174,509 |
|
|
|
Indirect Value
|
$248,293,330 |
|
|
| Total
Shares |
49,220,508 |
|
|
| Total
Value |
$264,467,838 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
31
|
4
|
|
Stock
price went up :
|
5
|
1
|
| Stock
price went down : |
26
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 120.0%
|
2,039.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Build A Bear Workshop Inc |
BBW |
Former Director of the... |
2017-09-29 |
142,043 |
2017-09-29 |
1,281,000 |
Premium* |
|
|
Prophase Labs Inc |
PRPH |
10% Owner |
|
0 |
2017-09-29 |
627,322 |
Premium* |
|
|
Orchids Paper Products Co /de |
TIS |
10% Owner |
2019-04-03 |
128,000 |
2019-04-03 |
1,329,963 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
10% Owner |
2022-10-26 |
247,500 |
2022-10-26 |
5,000,000 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2023-01-04 |
230,000 |
2023-01-04 |
1,767,774 |
Premium* |
|
|
Retractable Technologies Inc |
RVP |
10% Owner |
2022-12-29 |
387,500 |
2022-12-29 |
688,575 |
Premium* |
|
|
Astrotech Corporation |
ASTC |
10% Owner |
2022-12-02 |
350,000 |
2022-12-02 |
6,612,311 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2022-12-21 |
600,000 |
2022-12-21 |
6,160,570 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
10% Owner |
2022-11-21 |
150,000 |
2022-11-21 |
6,440,000 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
|
0 |
2024-02-07 |
9,395,934 |
Premium* |
|
|
Cyteir Therapeutics, Inc. |
CYT |
|
2024-03-20 |
335,000 |
2024-03-20 |
3,654,053 |
Premium* |
|
|
Reneo Pharmaceuticals, Inc. |
RPHM |
|
2024-05-14 |
1,020,769 |
2024-05-14 |
2,672,194 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-08-24 |
4 |
B |
$0.47 |
$79,554 |
I/I |
167,589 |
5,139,322 |
1.5 |
% |
|
| ASTC |
Astrotech Corporation |
10% Owner |
– – • |
2022-09-02 |
4 |
B |
$0.47 |
$61,017 |
I/I |
129,990 |
5,381,382 |
1.5 |
% |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-15 |
4 |
B |
$0.63 |
$525,663 |
I/I |
831,694 |
6,440,000 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-14 |
4 |
B |
$0.69 |
$3,868,609 |
I/I |
5,608,306 |
5,608,306 |
1.5 |
- |
|
| STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
– – • |
2022-11-21 |
4 |
B |
$0.71 |
$106,740 |
D/D |
150,000 |
150,000 |
2.45 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-16 |
4 |
B |
$1.11 |
$92,243 |
I/I |
83,199 |
3,017,774 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-03 |
4 |
B |
$1.14 |
$34,976 |
I/I |
30,800 |
2,931,945 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-06-06 |
4 |
B |
$1.16 |
$3,051 |
I/I |
2,630 |
2,934,575 |
1.42 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-05-16 |
4 |
B |
$1.17 |
$17,577 |
I/I |
15,000 |
2,875,000 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-05-17 |
4 |
B |
$1.26 |
$32,836 |
I/I |
26,145 |
2,901,145 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-10-08 |
4 |
B |
$1.30 |
$149,222 |
I/I |
114,910 |
2,087,906 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-10-09 |
4 |
B |
$1.30 |
$221,120 |
I/I |
169,975 |
2,257,881 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-11-05 |
4 |
B |
$1.32 |
$57,156 |
I/I |
43,300 |
2,301,181 |
1.5 |
- |
|
| IRON |
Disc Medicine, Inc |
10% Owner |
– – • |
2022-04-11 |
4 |
B |
$1.35 |
$681,057 |
I/I |
504,487 |
4,604,487 |
1.5 |
% |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-11-06 |
4 |
B |
$1.37 |
$10,275 |
I/I |
7,500 |
2,308,681 |
1.5 |
- |
|
| IRON |
Disc Medicine, Inc |
10% Owner |
– – • |
2022-04-12 |
4 |
B |
$1.37 |
$75,075 |
D/D |
55,000 |
270,000 |
2.45 |
% |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-09-23 |
4 |
B |
$1.38 |
$22 |
I/I |
16 |
1,951,558 |
1.42 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-11-07 |
4 |
B |
$1.38 |
$19,245 |
I/I |
13,946 |
2,322,627 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-22 |
4 |
B |
$1.38 |
$11,040 |
I/I |
8,000 |
2,860,000 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-09-18 |
4 |
B |
$1.40 |
$3,500 |
I/I |
2,500 |
1,907,500 |
1.42 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-09-22 |
4 |
B |
$1.40 |
$61,659 |
I/I |
44,042 |
1,951,542 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-09-24 |
4 |
B |
$1.40 |
$6,353 |
I/I |
4,538 |
1,956,096 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-10-02 |
4 |
B |
$1.40 |
$23,621 |
I/I |
16,900 |
1,972,996 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2022-04-21 |
4 |
B |
$1.40 |
$772,800 |
I/I |
552,000 |
2,852,000 |
1.5 |
- |
|
| PRPH |
Prophase Labs Inc |
10% Owner |
– – • |
2014-09-16 |
4 |
B |
$1.41 |
$14,100 |
I/I |
10,000 |
1,905,000 |
1.5 |
- |
|
175 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
